MIRA
INFORM REPORT
|
Report Date : |
26.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
SHREE GANESH REMEDIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No.6011, GIDC Estate, Near Aventis Pharma, Ankleshwar-393002, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
27.04.1995 |
|
|
|
|
Com. Reg. No.: |
04-025661 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.10.992
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230GJ1995PTC025661 |
|
|
|
|
IEC No.: |
3405004454 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAPFS3199F |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer, Importer and Exporter of Pharmaceuticals, Intermediates,
Fine Chemicals. |
|
|
|
|
No. of Employees
: |
27 (Approximately) (In Office – 7
and In Factory - 20) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (47) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 270000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a part of “Ganesh Group” It is an established company having a satisfactory track record. The company
has performed well during 2011-2012. Trade relations are reported to be fair. Business is active. Payments
are reported to be usually correct and as per commitments. The company can be considered for normal business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Mr. Chandubhai Manubhai Kothia |
|
Designation : |
Director |
|
Contact No.: |
91-9328301671 |
|
Date : |
25.04.2013 |
LOCATIONS
|
Registered Office / Factory : |
Plot No.6011, GIDC Estate, Near Aventis Pharma, Ankleshwar-393002, |
|
Tel. No.: |
91-2646-221564/ 227777/ 327778 |
|
Mobile No.: |
91-9328301671 (Mr. Chandubhai Manubhai Kothia) |
|
Fax No.: |
91-2646-226422 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
102590 Sq. ft |
|
Location : |
Leased |
|
|
|
|
Factory : |
303/C16, Tulsikunj Society, GIDC Estate, Ankleshwar, Bharuch-393002,
Gujarat, India |
|
Tel. No.: |
91-264-251059 |
|
Area : |
3168 Sq. ft |
|
Location : |
Leased |
DIRECTORS
AS ON 29.09.2012
|
Name : |
Mr. Chandubhai Manubhai Kothia |
|
Designation : |
Director |
|
Address : |
303/C16, Tulsikunj Society, GIDC Estate, Ankleshwar, Bharuch-393002,
Gujarat, India |
|
Date of Birth/Age : |
01.12.1962 |
|
Qualification : |
M.SC, D.Pharam |
|
Experience : |
22 Years |
|
Date of Appointment : |
27.04.1995 |
|
DIN No.: |
00652806 |
|
|
|
|
Name : |
Mr. Hasmukh Manubhai Kothia |
|
Designation : |
Director |
|
Address : |
406/15, Sardar Patel Society, GIDC Estate, Ankleshwar, Bharuch-393002,
Gujarat, India |
|
Date of Birth/Age : |
01.07.1955 |
|
Qualification : |
B.Sc., D. Pharm. |
|
Experience : |
22 Years |
|
Date of Appointment : |
27.04.1995 |
|
DIN No.: |
01076206 |
|
|
|
|
Name : |
Mr. Ashokkumar Manubhai Kothia |
|
Designation : |
Director |
|
Address : |
4, Navjeevan Co-operative Housing Society, GIDC, Estate, Ankleshwar, Bharuch-393002,
Gujarat, India |
|
Date of Birth/Age : |
01.06.1969 |
|
Qualification : |
B.Sc. |
|
Experience : |
22 Years |
|
Date of Appointment : |
27.04.1995 |
|
DIN No.: |
01076171 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2012
NOTE:
SHAREHOLDING DETAILS FILE ATTACHED.
AS ON 29.09.2012
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer, Importer and Exporter of Pharmaceuticals, Intermediates,
Fine Chemicals. |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceuticals, Intermediates, Fine Chemicals |
|
Countries : |
·
Japan ·
UK |
|
|
|
|
Imports : |
|
|
Products : |
Raw Material |
|
Countries : |
·
Egypt ·
UK ·
China ·
France ·
Malaysia |
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit |
|
|
|
|
Purchasing : |
Cash and Credit |
PRODUCTION STATUS [AS ON 31.03.2011]
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
Bulk Drug Intermediates and Fine Chemicals |
MT |
|
910.00 |
355.09 |
NOTE: - The above capacity has been absorbed during the year in the manufacturing of own goods as well as under job work.
GENERAL INFORMATION
|
Suppliers : |
·
Syntor Fine Chemical · Adarsh Hardware and Paints Stores · AH Chemicals Limited · Ajanta Corporation · Ajanta Polymers · Ambica Ice Industries · Akshar Electrics and Electronics · Analpa Industries · Are Enterpries · Ashok Impex · Bansal Marketing · BASP Chemical Products Limited · Bhagyalaxmi Steel Suppliers · Bhavani Hardware · Black Rose Industries Limited · Ganesh Corporation · Gayatri Chemicals Industries · H.B.Chemicals · Hindustan Speciality Chemicals · Jayant Packing Industries · Inter Plastica Private Limited · Kapadia Impex Mumbai · Luna Chemical Industries Private Limited ·
Manali Containers |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Customers : |
End Users · Agan Aroma and Fine Chemicals Limited · Ami Organics Private Limited · Amneal Pharmaceuticals Company Private Limited · Aniket Pharma Private Limited · Astrix laboratories Limited · Cadila Healthcare Limited · Colourtex Industries Limited · Chandra Life Sciences Private Limited · Dolphin Chem · Dayaram Chemicals Private Limited · Dr. Prems Molecules Private Limited · Hetero Labs Ltd (Unit - III) · IPCA Laboratories Limited · K. Rasiklal Exim Private Limited · Metro Chem API Private Limited (Unit - I) · Piramal Healthcare Limited · Pravin Laboratories Private Limited · Rakshit Pharmaceuticals Limited · Sharon Biomedicine Limited · Siddharth Interchem Private Limited · Survival Technologies Private Limited · Sun Pharmaceutical Industries Private Limited · Suyog Dyechemie Private Limited · Synth Services · Syntor Fine Chemicals Limited, England · ZCL Chemicals Limited |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
No. of Employees : |
27 (Approximately) (In Office – 7
and In Factory - 20) |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Bankers : |
· Axis Bank Limited Vardhman Complex, Opposite G.E.B Office, Race Cource (North), Vadodara-390007, Gujarat, India ·
State Bank of Saurashtra, GIDC, Ankleshwar,
Gujarat, India ·
Bank of Baroda |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
J.R. Kakadiya and Company Chartered Accountants |
|
Address : |
A-205, City Centre, Near Reshambhavan, Lal Darwaja Surat-395003,
Gujarat, India |
|
Tel. No.: |
91-2646-238241 |
|
Mobile No.: |
91-9925004220 |
|
E-Mail : |
|
|
PAN No: |
AAEFJ8607Q |
|
|
|
|
Associates/Subsidiaries : |
·
Shree
Ganesh Chemicals Address: Plot No.6715, GIDC Estate, Ankleshwar, District Bharuch, Gujarat,
India ·
Shree
Ganesh Pigments Private Limited Address: A-1, 405, GIDC, Ankleshwar, District Bharuch, Gujarat, India ·
Ashok Pharma Chem ·
Ashok Impex ·
Ganesh Corporation ·
Ankleshwar Research and Analytical Infrastructure
Limited |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1500000 |
Equity Shares |
Rs.10/- each |
Rs.15.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1099226 |
Equity Shares |
Rs.10/- each
|
Rs.10.992
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
10.992 |
10.297 |
10.297 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
58.962 |
38.920 |
29.560 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
69.954 |
49.217 |
39.857 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
27.699 |
15.568 |
19.752 |
|
|
2] Unsecured Loans |
0.000 |
4.351 |
4.919 |
|
|
TOTAL BORROWING |
27.699 |
19.919 |
24.671 |
|
|
DEFERRED TAX LIABILITIES |
1.371 |
1.391 |
1.102 |
|
|
|
|
|
|
|
|
TOTAL |
99.024 |
70.527 |
65.630 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
38.872 |
35.851 |
33.399 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.500 |
0.500 |
0.450 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
24.639
|
14.116 |
9.327 |
|
|
Sundry Debtors |
43.959
|
21.062 |
36.020 |
|
|
Cash & Bank Balances |
1.765
|
11.850 |
1.827 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
13.209
|
11.027 |
15.467 |
|
Total
Current Assets |
83.572
|
58.055 |
62.641 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
12.468
|
17.397 |
22.826 |
|
|
Other Current Liabilities |
0.000
|
0.000 |
0.000 |
|
|
Provisions |
11.452
|
6.482 |
8.034 |
|
Total
Current Liabilities |
23.920
|
23.879 |
30.860 |
|
|
Net Current Assets |
59.652
|
34.176 |
31.781 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
99.024 |
70.527 |
65.630 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
|
|
108.142 |
129.337 |
|
|
|
Other Income |
|
3.214 |
3.031 |
|
|
|
TOTAL (A) |
156.004 |
111.356 |
132.368 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Material Costs |
|
61.046 |
61.576 |
|
|
|
Manufacturing and Operating Expenses |
|
13.831 |
21.237 |
|
|
|
Employee's Remuneration and Benefits |
125.121 |
6.474 |
5.388 |
|
|
|
Sales & Administrative Expenses |
|
11.450 |
16.497 |
|
|
|
Preliminary Expenses |
|
0.000 |
0.073 |
|
|
|
Increase / Decrease in Stock |
|
(0.448) |
(0.400) |
|
|
|
TOTAL (B) |
125.121 |
[Including
Financial Expenses] |
[Including
Financial Expenses] |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
30.883 |
|
|
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
2.134 |
|
|
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
28.749 |
19.003 |
27.997 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
5.250 |
5.017 |
3.350 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
23.499 |
13.986 |
24.647 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
7.626 |
4.626 |
8.276 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
15.873 |
9.360 |
16.371 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
34.811 |
25.451 |
9.088 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Advance Carried Forward |
0.000 |
0.000 |
0.008 |
|
|
BALANCE CARRIED
TO THE B/S |
50.684 |
34.811 |
25.451 |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
15.33 |
9.09 |
22.25 |
|
|
Particulars |
|
|
31.03.2013 |
|
Sales Turnover [Approximately] |
|
|
127.800 [Due to market
fluctuation] |
Expected Sales (2013-14) : Rs.150.000 Millions.
The above information has been parted by Mr. Chandubhai Manubhai Kothia.
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
10.17
|
8.41
|
12.37 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
12.93
|
19.06 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
19.19
|
14.89
|
25.66 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.34
|
0.28
|
0.62 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.40
|
0.40
|
0.62 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
3.49
|
2.43
|
2.03 |
LOCAL AGENCY FURTHER INFORMATION
DETAILS OF SUNDRY CREDITORS:
|
Particulars |
31.03.2012 [Rs. in millions] |
31.03.2011 [Rs. in millions] |
31.03.2010 [Rs. in millions] |
|
Sundry Creditors |
12.468
|
17.397 |
22.826 |
|
Sr. No. |
Check List by
Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Yes |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
Yes |
|
14] |
Estimation for coming financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
Yes |
|
18] |
Major customers |
Yes |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details (if applicable) |
Yes |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
PAN of Proprietor/Partner/Director, if available |
No |
|
32] |
Date
of Birth of Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
No |
|
Unsecured Loan |
As
on 31.03.2012 [Rs.
in Millions] |
As
on 31.03.2011 [Rs.
in Millions] |
|
Loans and Advances From Related Parties |
0.000 |
4.351 |
|
TOTAL
|
0.000 |
4.351 |
BANKERS CHARGES
REPORT AS PER REGISTRY
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified |
10090137 |
|
Corporate
identity number of the company |
U24230GJ1995PTC025661 |
|
Name of the
company |
SHREE GANESH REMEDIES
PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
Plot No.6011, GIDC Estate, Near Aventis Pharma, Ankleshwar-393002, |
|
Type of charge |
Book Debts Movable Property
[not being pledge] |
|
Particular of
charge holder |
Axis Bank Limited Vardhman Complex, Opposite G.E.B Office, Race Cource (North), Vadodara-390007, Gujarat, India Email: anup.nihalani@axisbank.com |
|
Nature of
description of the instrument creating or modifying the charge |
Deed of
hypothecation |
|
Date of
instrument Creating the charge |
29.02.2012 |
|
Amount secured by
the charge |
Rs.51.490
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest SIDBI Loan: Rs. 9.990
Millions - ROI 11.50% Rs.5.000 Millions
- ROI 11.00% Rs.7.500 Millions
- ROI 11.00% payable on10th
day of each month Axis Loan: CC Rs.19.000
Millions -ROI 13% LC Sub limit Rs.
10.000 Millions Terms of Repayment SIDBI Loan: Loan of Rs.9.990
Millions - 20 Installments (19x0.500 Millions + 4.90x1) Loan of Rs.5.000
Millions - 60 Installments (59x84000 + 1x44000) Loan of Rs.7.500
Millions - 48 Installments (47x155000 +1x215000) All becoming due
on 10th of each month Axis Bank: CC Rs. 19.000
Millions - on Demand LC Rs. 10.000
Millions - on Demand Margin Axis Bank: LC Rs. 10.000
Millions - 15% Margin CC - 25% on Stock
and 40% on Book Debts Extent and Operation of the charge Extent and
Operation of the Charge is 100% |
|
Short particulars
of the property charged |
All current
assets of the borrower incl. Stocks, raw materials stock in process, finished
and semi finished goods, consumables stores and book debts and all other
receivables etc, both present and future |
|
Date of latest
modification prior to the present modification |
02.12.2011 |
|
Particulars of
the present modification |
Axis Bank Limited
had vide Letter No. Axis B/VAD/CR/11-12/1613 had permitted SIDBI to create
second charge to the extent of Rs.22.490 Millions over the current assets of
the borrower charged as primary security towards various credit facilities
from Axis Bank Ltd, who continues to hold first charge for Rs.29.000
Millions. Pursuant to the above, SIDBI has hypothecated the said assets on
second charge basis vide hypothecation deed dt.29/02/2012. |
COMMITMENTS AND
CONTINGENT ASSETS & LIABILITIES
Rs. in Millions
|
Contingent
Liabilities |
31.03.2012 |
31.03.2011 |
|
Bank Guarantee to CBEC - Customs Guarantee |
1.134 |
1.134 |
FIXED ASSETS:
· Plant and Machinery
· Electrical Installation
· Furniture and Fixtures
· ETP Machinery
· Factory Building
· Gas Connection
· Instalation and Erection
· Computer
· Laboratory Equipment
· Air Conditioner
· Motor Car
· Toyota Innova 2.5L VX-7S
· Mobile Instrument
· Telephone Instrument
· Vehicle
· Cycles
· Photocopier Device
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.17 |
|
|
1 |
Rs.82.99 |
|
Euro |
1 |
Rs.70.62 |
INFORMATION DETAILS
|
Information
Gathered by : |
SVA |
|
|
|
|
Report Prepared
by : |
TPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
47 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.